Navigation Links
Drugs May Help Healthy Men Lower Prostate Cancer Risk
Date:2/24/2009

New guidelines suggest that men discuss use of medicines such as Propecia with their doctor

TUESDAY, Feb. 24 (HealthDay News) -- Healthy men with no signs of prostate cancer may wish to talk to their doctors about taking a drug that could further reduce their risk for the disease, new guidelines suggest.

The American Society of Clinical Oncology and the American Urological Association have issued new guidelines recommending that these men talk to their doctors about using a 5-alpha reductase inhibitors (5-ARI). These drugs -- which include finasteride (Propecia), used to treat male pattern baldness -- can reduce levels of dihydrotestosterone (DHT), a hormone that spurs prostate cancer development.

Previous studies have been shown that 5-ARIs reduce risk of contracting the illness by 25 percent.

Prostate cancer is the second-leading cause of death by cancer in men.

"Although one in every six men in the United States will be diagnosed with prostate cancer, we are not recommending that all men take 5-ARIs," co-chair of the guideline panel Dr. Barnett S. Kramer, associate director for disease prevention at the National Institutes of Health, stressed in a news release issued by the organizations. "However, we would encourage men to begin a dialogue with their doctors to determine if they could benefit from taking 5-ARIs to reduce their prostate cancer risk."

The guidelines call for doctors to discuss the pro and cons of a 5-ARI with male patients who score a 3.0 or lower on a prostate-specific antigen (PSA) test, show no signs of prostate cancer, and receive (or plan to receive) regular disease screening.

The guidelines also suggest that men already taking a 5-ARI for other conditions should discuss continuing the medication as a way to prevent prostate cancer. Today, 5-ARIs are used to treat male-pattern baldness and benign prostatic hyperplasia (enlarged prostate) among other non-cancerous conditions.

While supporting the guidelines, panel co-chair Dr. Paul F. Schellhammer noted that while 5-ARIs may decrease the risk of getting prostate cancer, it is not known whether these drugs reduce death from the disease.

"However, the demonstrated effect of 5-ARIs in reducing prostate cancer incidence makes it reasonable to recommend them for use to prevent the disease," he said in the same news release.

The guidelines are scheduled to appear in the March issue of the Journal of Clinical Oncology and The Journal of Urology.

More information

The U.S. National Cancer Institute has more about prostate cancer.



-- Kevin McKeever



SOURCE: American Society of Clinical Oncology/American Urological Association, news release, Feb. 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Finding May Lead to New Drugs for Urinary Infections
2. Rheumatoid Arthritis Drugs Raise Shingles Risk
3. Asthma drugs need to be maintained for continued benefit
4. Doctors Guide to Cancer Drugs May Need Revising
5. Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009
6. New guidelines for prescribing opioid pain drugs published
7. New Guidelines for Prescribing Opioid Pain Drugs Published
8. New guideline for prescribing opioid pain drugs published
9. Fertility Drugs Do Not Increase Ovarian Cancer Risk
10. drugstore.com inc. Reports Profitable Fourth Quarter of 2008 and Free Cash Flow of $5.4 Million on Record OTC Sales
11. Drugs from Biogen Idec and Merck are the Most Promising Therapies in Development in the Acute Heart Failure Market
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drugs May Help Healthy Men Lower Prostate Cancer Risk
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology: